Company Legal Name
Latest Valuation
Founded Year
Headquarters
Chai Discovery develops artificial intelligence tools for predicting biomolecular structures and designing de novo therapeutic antibodies. Based in San Francisco, the company leverages advanced computational methods to accelerate drug discovery processes, offering pharmaceutical companies and research institutions enhanced capabilities for protein structure prediction and antibody engineering. Their AI-driven platform addresses critical bottlenecks in therapeutic development by providing accurate molecular modeling and novel antibody design solutions. With the global antibody therapeutics market experiencing rapid growth and increasing demand for computational drug discovery tools, Chai Discovery is positioned to capitalize on the convergence of artificial intelligence and biotechnology innovation.
Availability of information and platform features may vary by region and applicable requirements.
Eligibility and access may depend on user location, verification status, and applicable legal or regulatory requirements.
Additional platform details may be available after account creation, where applicable.
Identity, compliance, and other review steps may be required before access to certain materials or features.
Platform details, if applicable, should be reviewed in account materials before making any decision.
Any economic terms, if applicable, should be reviewed carefully in the relevant materials.
Private market interests may be illiquid, restricted, or difficult to transfer. Users should not assume that any secondary market will be available.
Valuations may reflect past financing rounds or other available information and may not represent a price at which any person can transact.
Company and sector risks may vary by business model, technology development, competition, regulation, and market conditions.
Operational, documentation, custody, or verification processes may involve limitations, delays, or dependencies.
Regulatory, tax, and legal requirements may change and may affect information availability, platform features, or user eligibility.
